These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35885439)

  • 1. Combinatorial Analysis of Circulating Biomarkers and Maternal Characteristics for Preeclampsia Prediction in the First and Third Trimesters in Asia.
    Lin W; Teng SW; Lin TY; Lovel R; Sung HY; Chang WY; Wu TB; Chen HY; Wang LM; Shaw SW
    Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
    Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.
    Aminuddin NA; Sutan R; Mahdy ZA; Rahman RA; Nasuruddin DN
    PLoS One; 2022; 17(3):e0265080. PubMed ID: 35275947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia.
    Bian X; Biswas A; Huang X; Lee KJ; Li TK; Masuyama H; Ohkuchi A; Park JS; Saito S; Tan KH; Yamamoto T; Dietl A; Grill S; Verhagen-Kamerbeek WDJ; Shim JY; Hund M
    Hypertension; 2019 Jul; 74(1):164-172. PubMed ID: 31188674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
    Chaemsaithong P; Pooh RK; Zheng M; Ma R; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Wataganara T; Yeo GSH; Wright A; Leung WC; Sekizawa A; Hu Y; Naruse K; Saito S; Sahota D; Leung TY; Poon LC
    Am J Obstet Gynecol; 2019 Dec; 221(6):650.e1-650.e16. PubMed ID: 31589866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.
    Park HJ; Kim SH; Jung YW; Shim SS; Kim JY; Cho YK; Farina A; Zanello M; Lee KJ; Cha DH
    BMC Pregnancy Childbirth; 2014 Jan; 14():35. PubMed ID: 24444293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of angiogenic and antiangiogenic factors in the second trimester in the prediction of preeclampsia in pregnant women with type 1 diabetes.
    Holmes VA; Young IS; Patterson CC; Maresh MJ; Pearson DW; Walker JD; McCance DR;
    Diabetes Care; 2013 Nov; 36(11):3671-7. PubMed ID: 23920083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers.
    Pihl K; Sørensen S; Stener Jørgensen F
    Fetal Diagn Ther; 2020; 47(4):277-283. PubMed ID: 31622970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester pre-eclampsia biomarker profiles in Asian population: multicenter cohort study.
    Chaemsaithong P; Sahota D; Pooh RK; Zheng M; Ma R; Chaiyasit N; Koide K; Shaw SW; Seshadri S; Choolani M; Panchalee T; Yapan P; Sim WS; Sekizawa A; Hu Y; Shiozaki A; Saito S; Leung TY; Poon LC
    Ultrasound Obstet Gynecol; 2020 Aug; 56(2):206-214. PubMed ID: 31671479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective.
    Hodel M; Blank PR; Marty P; Lapaire O
    Dis Markers; 2019; 2019():4096847. PubMed ID: 31485276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study.
    Ohkuchi A; Saito S; Yamamoto T; Minakami H; Masuyama H; Kumasawa K; Yoshimatsu J; Nagamatsu T; Dietl A; Grill S; Hund M
    Hypertens Res; 2021 Jul; 44(7):813-821. PubMed ID: 33727707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
    Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PP086. The modern search for possible predictors of preeclampsia in the first trimester of pregnancy (preliminary study).
    Khodzhaeva ZS; Ivanets TY; Alexeeva ML; Kholin AM; Akatyeva AS; Vavina OV; Sukhikh GT
    Pregnancy Hypertens; 2012 Jul; 2(3):287. PubMed ID: 26105408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio: A Prospective Cohort Study of Unselected Nulliparous Women.
    Sovio U; Gaccioli F; Cook E; Hund M; Charnock-Jones DS; Smith GC
    Hypertension; 2017 Apr; 69(4):731-738. PubMed ID: 28167687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mean arterial pressure for predicting preeclampsia in Asian women: a longitudinal cohort study.
    Zhu J; Zhang J; Syaza Razali N; Chern B; Tan KH
    BMJ Open; 2021 Aug; 11(8):e046161. PubMed ID: 34389562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia Study.
    Gao J; Huang X; Di W; Dong X; Gou W; Shi H; Wang Z; Dietl A; Grill S; Hund M
    Front Cardiovasc Med; 2021; 8():602560. PubMed ID: 34497833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic factors during pregnancy in Asian women with elevated blood pressure in early pregnancy and the risk of preeclampsia: a longitudinal cohort study.
    Zhu J; Zhang J; Ng MJ; Chern B; Yeo GS; Tan KH
    BMJ Open; 2019 Dec; 9(11):e032237. PubMed ID: 31791965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
    Stepan H; Hund M; Andraczek T
    Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of the sFlt-1/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study.
    Ohkuchi A; Masuyama H; Yamamoto T; Kikuchi T; Taguchi N; Wolf C; Saito S
    Hypertens Res; 2021 Jul; 44(7):822-829. PubMed ID: 33594274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.